SCHEMBL19558648

SCHEMBL19558648

CC(C)c1cnc(O)c(NS(=O)(=O)c2cccc(C(=O)O)c2)c1

nearest known ligand 0.53

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ KDM4E B2RXH2 2/20 0.52
▸ TSHR P16473 1/20 0.52
▸ PTK2B Q14289 1/20 0.52
▸ KMT2A Q03164 3/20 0.51
▸ MAPT P10636 1/20 0.48
▸ AKR1C3 P42330 1/20 0.48
▸ ACLY P53396 1/20 0.47
▸ CASP3 P42574 1/20 0.47
▸ SENP8 Q96LD8 1/20 0.47
▸ SENP7 Q9BQF6 1/20 0.47
▸ SENP6 Q9GZR1 1/20 0.47
▸ MEN1 O00255 1/20 0.46
▸ CA1 P00915 2/20 0.45
▸ CA2 P00918 2/20 0.45
▸ ALDH1A1 P00352 2/20 0.44
▸ TDP1 Q9NUW8 1/20 0.44
▸ PIK3C2B O00750 1/20 0.44
▸ PIK3C2G O75747 1/20 0.44
▸ PFKFB3 Q16875 1/20 0.44
▸ RAB9A P51151 1/20 0.43

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL13976075 0.86 ACLY (0.53) KDM4ETSHRPTK2BKMT2AAKR1C3
SCHEMBL24139986 0.85 KDM4E (0.48) KDM4ETSHRPTK2BKMT2AMAPT
SCHEMBL16020314 0.85 KDM4E (0.55) KDM4ETSHRPTK2BKMT2AMAPT
SCHEMBL16017553 0.82 KDM4E (0.52) KDM4ETSHRPTK2BKMT2AMAPT
SCHEMBL18136984 0.82 KDM4E (0.52) KDM4ETSHRPTK2BKMT2AMAPT
SCHEMBL24140000 0.79 AKR1C3 (0.56) KDM4ETSHRPTK2BKMT2AMAPT
SCHEMBL19558829 0.78 ACLY (0.51) KDM4ETSHRPTK2BKMT2AAKR1C3
SCHEMBL13975447 0.77 SLC40A1 (0.55) KMT2AACLYMEN1ALDH1A1
SCHEMBL16235212 0.73 SLC40A1 (0.58) KDM4ETSHRPTK2BKMT2AACLY
SCHEMBL18136822 0.73 CASP3 (0.49) KDM4ETSHRPTK2BKMT2AMAPT

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-9808466-B2 Macrocyclic compounds as protein kinase inhibitors FUNDACIÓN CENTRO NACIONAL DE INVESTIGACIONES ONCOLOGICAS CARLOS III 2017-11-07 — — US disclosed
Send feedback